Skip to content
Screener

Quest Diagnostics DGX Q4 2025 Annual earnings

Reported February 10, 2026 · Before market open

Revenue$2.8BBeat by $51.8M
EPS$2.42Beat by $0.06
Revenue estimate$2.8B
EPS estimate$2.36

Next report

Oct 20, 2026 (in 2 months)
Revenue estimate$3.0B
EPS estimate$2.85

Financials

Q4 2025

Income statement

See full
Revenue$2.8B+7.1%
Gross profit$910.0M+6.1%
Operating income$386.0M+6.9%
Net income$245.0M+10.4%
EPS (diluted)$2.18+11.8%

Balance sheet

See full
Cash & equivalents$420.0M-23.5%
Total debt$6.4B-7.8%
Total equity$7.2B+5.8%
Total assets$16.2B+0.4%

Cash flow

See full
Operating cash flow$465.0M+0.2%
CapEx$158.0M+28.5%
Free cash flow$307.0M-10.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$19.3B+14.6%
Enterprise value$25.29B+8.8%
P/E19.5×+0.1×
P/S1.7×0.0×

Profitability

See full
Gross margin33.2%+0.4pp
Operating margin14.1%+0.5pp
Net margin9%+0.2pp
FCF margin12.3%+3.1pp

Returns & leverage

See full
Return on equity14.2%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1×-0.1×

Segments

By segment

See full
DIS business$2.7B+7.3%
All other operating segments$64.0M-1.5%

FAQ

When did Quest Diagnostics report Q4 2025 earnings?
Quest Diagnostics (DGX) reported Q4 2025 earnings on February 10, 2026 before market open.
What were Quest Diagnostics's Q4 2025 revenue and EPS?
Quest Diagnostics reported revenue of $2.8B and eps of $2.42 for Q4 2025.
Did Quest Diagnostics beat estimates in Q4 2025?
Revenue beat the consensus estimate of $2.8B by $51.8M. EPS beat the consensus estimate of $2.36 by $0.06.
How did Quest Diagnostics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.1% from $2.6B a year earlier and eps grew 8.5% from $2.23.
Where can I find Quest Diagnostics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001022079-26-000005) and the 10-K periodic report (0001022079-26-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.